Schlit AF et al. |
Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives. |
1995 |
Contraception |
pmid:7750285
|
Nüsing RM et al. |
Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide. |
2001 |
Clin. Pharmacol. Ther. |
pmid:11673754
|
Renda G et al. |
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. |
2006 |
Clin. Pharmacol. Ther. |
pmid:16952493
|
Lee CR et al. |
Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study. |
2008 |
Clin. Pharmacol. Ther. |
pmid:17495879
|
Cipollone F et al. |
Effects of nabumetone on prostanoid biosynthesis in humans. |
1995 |
Clin. Pharmacol. Ther. |
pmid:7554708
|
Oosaki R et al. |
Correlation among urinary eosinophil protein X, leukotriene E4, and 11-dehydrothromboxane B2 in patients with spontaneous asthmatic attack. |
1998 |
Clin. Exp. Allergy |
pmid:9761018
|
Gonçalves LH et al. |
Acetylsalicylic acid therapy: influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels. |
2014 |
Clin. Chim. Acta |
pmid:24316050
|
Gonçalves LH et al. |
Urinary 11-dehydro thromboxane Bâ‚‚ levels in type 2 diabetic patients before and during aspirin intake. |
2011 |
Clin. Chim. Acta |
pmid:21510926
|
Lowe FJ et al. |
Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers. |
2009 |
Clin. Chem. Lab. Med. |
pmid:19676143
|
Djurup R et al. |
Rapid, direct enzyme immunoassay of 11-keto-thromboxane B2 in urine, validated by immunoaffinity/gas chromatography-mass spectrometry. |
1993 |
Clin. Chem. |
pmid:8252718
|
Karon BS et al. |
Aspirin responsiveness in healthy volunteers measured with multiple assay platforms. |
2008 |
Clin. Chem. |
pmid:18420732
|
Fiorucci S et al. |
NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide. |
2002 |
Circulation |
pmid:12473561
|
Rouvier J et al. |
Aspirin resistance. |
2002 |
Circulation |
pmid:12473569
|
Minuz P et al. |
Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. |
2002 |
Circulation |
pmid:12451006
|
Hennekens CH et al. |
Terms and conditions: semantic complexity and aspirin resistance. |
2004 |
Circulation |
pmid:15381661
|
Belton O et al. |
Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. |
2000 |
Circulation |
pmid:10952950
|
Reilly M et al. |
Modulation of oxidant stress in vivo in chronic cigarette smokers. |
1996 |
Circulation |
pmid:8964113
|
Davì G et al. |
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. |
2003 |
Circulation |
pmid:12810609
|
Patrignani P et al. |
Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. |
2000 |
Circulation |
pmid:10920066
|
Davì G et al. |
Oxidative stress and platelet activation in homozygous homocystinuria. |
2001 |
Circulation |
pmid:11535567
|
Maree AO and Fitzgerald DJ |
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. |
2007 |
Circulation |
pmid:17452618
|
Cipollone F et al. |
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. |
2002 |
Circulation |
pmid:12135935
|
Capone ML et al. |
Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. |
2004 |
Circulation |
pmid:15037526
|
Eikelboom JW et al. |
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. |
2002 |
Circulation |
pmid:11940542
|
Davì G et al. |
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. |
1999 |
Circulation |
pmid:9892587
|
Cipollone F et al. |
Modulation of aspirin-insensitive eicosanoid biosynthesis by 6-methylprednisolone in unstable angina. |
2003 |
Circulation |
pmid:12515743
|
Eikelboom JW et al. |
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk. |
2008 |
Circulation |
pmid:18838564
|
Larsson PT et al. |
Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. |
1994 |
Circulation |
pmid:8181117
|
Cattaneo M |
Letter by cattaneo regarding article, "incomplete inhibition of thromboxane biosynthesis by acetylsalicylic Acid: determinants and effect on cardiovascular risk". |
2009 |
Circulation |
pmid:19546394
|
Nakamura A et al. |
Oral administration of a novel long-acting prostacyclin agonist with thromboxane synthase inhibitory activity for pulmonary arterial hypertension. |
2013 |
Circ. J. |
pmid:23676973
|
DeFilippis AP et al. |
Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction. |
2013 |
Circ. J. |
pmid:23985963
|
Santilli F et al. |
Pentraxin 3 and Platelet Activation in Obese Patients After Gastric Banding. |
2016 |
Circ. J. |
pmid:26632534
|
Gao F et al. |
Effect of polymorphism and type II diabetes on aspirin resistance in patients with unstable coronary artery disease. |
2011 |
Chin. Med. J. |
pmid:21740787
|
Tanaka S et al. |
High dose of inhaled fluticasone reduces high levels of urinary leukotriene E4 in the early morning in mild and moderate nocturnal asthma. |
2003 |
Chest |
pmid:14605047
|
Obase Y et al. |
Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma. |
1998 |
Chest |
pmid:9792572
|
Kurokawa K et al. |
Circadian characteristics of urinary leukotriene E(4) in healthy subjects and nocturnal asthmatic patients. |
2001 |
Chest |
pmid:11742908
|
Obase Y et al. |
Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. |
2002 |
Chest |
pmid:11796443
|
Ferretti A and Flanagan VP |
Mass spectrometric evidence for the anomalous chemical behavior of 11-dehydrothromboxane B2. |
1995 |
Chem. Phys. Lipids |
pmid:7586090
|
Helgason CM et al. |
Platelet aggregation and recruitment with aspirin-clopidogrel therapy. |
2008 |
Cerebrovasc. Dis. |
pmid:18349532
|
Dippel DW et al. |
What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke? |
2004 |
Cerebrovasc. Dis. |
pmid:15026612
|
Martinuzzo ME et al. |
Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies. |
2001 |
Br. J. Haematol. |
pmid:11564073
|
Coppola A et al. |
Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype. |
2005 |
Br. J. Haematol. |
pmid:16173969
|
Wallén NH et al. |
Effects of treatment with oral isosorbide dinitrate on platelet function in vivo; a double-blind placebo-controlled study in patients with stable angina pectoris. |
1994 |
Br J Clin Pharmacol |
pmid:7946939
|
Floyd CN et al. |
Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects. |
2014 |
Br J Clin Pharmacol |
pmid:25099258
|
Warner JH et al. |
Adaptive regression modeling of biomarkers of potential harm in a population of U.S. adult cigarette smokers and nonsmokers. |
2010 |
BMC Med Res Methodol |
pmid:20233412
|
Wang ZY et al. |
Comparative study of platelet activation markers in diabetes mellitus patients complicated by cerebrovascular disease. |
2001 |
Blood Coagul. Fibrinolysis |
pmid:11685040
|
Dharmasaroja PA and Sae-Lim S |
Effects of different doses, enteric-coated preparation of aspirin, and sex on urinary 11-dehydrothromboxane B2 in healthy volunteers. |
2010 |
Blood Coagul. Fibrinolysis |
pmid:20689403
|
Bridges AB et al. |
Circadian variation of endothelial cell function, red blood cell deformability and dehydro-thromboxane B2 in healthy volunteers. |
1991 |
Blood Coagul. Fibrinolysis |
pmid:1932530
|
Dharmasaroja PA et al. |
Aspirin nonresponders in patients with ischaemic stroke. |
2013 |
Blood Coagul. Fibrinolysis |
pmid:23429255
|
Landolfi R et al. |
Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. |
1992 |
Blood |
pmid:1327286
|